Delivery Order SPE2DB24D1034-SPE2DB25FVYY4

Award Date 12/5/24
Potential Completion Date 12/6/24
Potential Value $24K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
  • SPE2DB24D1034
    Indefinite Delivery Contract
  • SPE2DB24D1034-SPE2DB25FVYY4
    Delivery Order

This federal contract award, with ID SPE2DB24D1034|SPE2DB25FVYY4, is for the delivery of 4,566,620,604 units of the pharmaceutical product ATOVAQUONE-PROGUANIL 250-100 100S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $24,468.00 and is a Firm Fixed Price Delivery Order contract, with a completion date of December 6, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management (SAM.gov) and plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 3/6/25, 9:44 AM